GRI Bio, Inc. (GRI)
Nasdaq: GRI · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2020
Who runs GRI Bio, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Baker David Charles
Chief Executive Officer. First filing Feb 2021, latest Sep 22, 2025, 1 filing in all.
Officers reporting now
4
of 7 people with a filing in the last fifteen months
Directors reporting now
3
14 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Baker David Charles | Chief Executive Officer | Feb 2021 | Sep 22, 2025 | none |
| Hertz Walter Marc | Chief Executive Officer | Apr 2023 | Sep 22, 2025 | none |
| Kelly Leanne M. | Chief Financial Officer | May 2021 | Sep 22, 2025 | none |
| Chaturvedi Vipin | Chief Scientific Officer | Apr 2023 | Sep 22, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Rongen Roelof | director | Apr 2023 | Sep 22, 2025 | none |
| Simpson Camilla V | director | Apr 2023 | Sep 22, 2025 | none |
| Szekeres David Leslie | director | Apr 2023 | Sep 22, 2025 | none |
Earlier names on the record9, newest filing first
Agro Albert · officer · last filing Apr 2023Thorell Marella · director · last filing Dec 2022Ammer Richard · director · last filing Jun 2022Payne Joseph E · director · last filing Jun 2022Chhabra Meenu · director · last filing Mar 2022Toren Penny · officer · last filing May 2021Levi Ofir · director · last filing May 2021Salmon Pharma Gmbh · 10% owner · last filing Feb 2021Arcturus Therapeutics Holdings Inc. · 10% owner · last filing Feb 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.